Priorities in colorectal cancer research: Recommendations from the Gastrointestinal Scientific Leadership Council of the Coalition of Cancer Cooperative Groups

Peter J. O'Dwyer, S Gail Eckhardt, Daniel G. Haller, Joel Tepper, Dennis Ahnen, Stanley Hamilton, Al B. Benson, Mace Rothenberg, Nicholas Petrelli, Heinz Joseph Lenz, Robert Diasio, Raymond DuBois, Daniel Sargent, Jeff Sloan, C. Daniel Johnson, Robert L. Comis, Michael J. O'Connell

Research output: Contribution to journalReview article

22 Citations (Scopus)

Abstract

Emerging technologies have greatly expanded our ability to detect, characterize, and treat colorectal cancer. The Coalition of Cancer Cooperative Groups convened a multidisciplinary panel, the Scientific Leadership Council in GI cancer, to discuss and advise on the priorities and opportunities to advance current and future approaches into the clinical arena to impact most rapidly the morbidity and mortality from this disease. The Council's recommendations for research priorities are the result of engagement of community and academic oncologists, patient advocacy groups, and other stakeholders including the pharmaceutical industry and governmental agencies. We detail some key prospects for investigation in the areas of colon cancer detection, prevention, and surgical and medical management. Many are in early or definitive clinical trials, and a focus on rapid accrual is urged. The implementation of biology-directed laboratory investigations, both in association with ongoing clinical trials and as a separate developmental strategy for targeted therapies, is supported as the route to individualized therapy.

Original languageEnglish (US)
Pages (from-to)2313-2321
Number of pages9
JournalJournal of Clinical Oncology
Volume25
Issue number16
DOIs
StatePublished - Jun 1 2007

Fingerprint

Colorectal Neoplasms
Clinical Trials
Patient Advocacy
Aptitude
Drug Industry
Research
Colonic Neoplasms
Neoplasms
Technology
Morbidity
Mortality
Therapeutics
Oncologists

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Priorities in colorectal cancer research : Recommendations from the Gastrointestinal Scientific Leadership Council of the Coalition of Cancer Cooperative Groups. / O'Dwyer, Peter J.; Eckhardt, S Gail; Haller, Daniel G.; Tepper, Joel; Ahnen, Dennis; Hamilton, Stanley; Benson, Al B.; Rothenberg, Mace; Petrelli, Nicholas; Lenz, Heinz Joseph; Diasio, Robert; DuBois, Raymond; Sargent, Daniel; Sloan, Jeff; Johnson, C. Daniel; Comis, Robert L.; O'Connell, Michael J.

In: Journal of Clinical Oncology, Vol. 25, No. 16, 01.06.2007, p. 2313-2321.

Research output: Contribution to journalReview article

O'Dwyer, PJ, Eckhardt, SG, Haller, DG, Tepper, J, Ahnen, D, Hamilton, S, Benson, AB, Rothenberg, M, Petrelli, N, Lenz, HJ, Diasio, R, DuBois, R, Sargent, D, Sloan, J, Johnson, CD, Comis, RL & O'Connell, MJ 2007, 'Priorities in colorectal cancer research: Recommendations from the Gastrointestinal Scientific Leadership Council of the Coalition of Cancer Cooperative Groups', Journal of Clinical Oncology, vol. 25, no. 16, pp. 2313-2321. https://doi.org/10.1200/JCO.2006.08.6900
O'Dwyer, Peter J. ; Eckhardt, S Gail ; Haller, Daniel G. ; Tepper, Joel ; Ahnen, Dennis ; Hamilton, Stanley ; Benson, Al B. ; Rothenberg, Mace ; Petrelli, Nicholas ; Lenz, Heinz Joseph ; Diasio, Robert ; DuBois, Raymond ; Sargent, Daniel ; Sloan, Jeff ; Johnson, C. Daniel ; Comis, Robert L. ; O'Connell, Michael J. / Priorities in colorectal cancer research : Recommendations from the Gastrointestinal Scientific Leadership Council of the Coalition of Cancer Cooperative Groups. In: Journal of Clinical Oncology. 2007 ; Vol. 25, No. 16. pp. 2313-2321.
@article{f880ce18302b4d9fb58854e22981f0e7,
title = "Priorities in colorectal cancer research: Recommendations from the Gastrointestinal Scientific Leadership Council of the Coalition of Cancer Cooperative Groups",
abstract = "Emerging technologies have greatly expanded our ability to detect, characterize, and treat colorectal cancer. The Coalition of Cancer Cooperative Groups convened a multidisciplinary panel, the Scientific Leadership Council in GI cancer, to discuss and advise on the priorities and opportunities to advance current and future approaches into the clinical arena to impact most rapidly the morbidity and mortality from this disease. The Council's recommendations for research priorities are the result of engagement of community and academic oncologists, patient advocacy groups, and other stakeholders including the pharmaceutical industry and governmental agencies. We detail some key prospects for investigation in the areas of colon cancer detection, prevention, and surgical and medical management. Many are in early or definitive clinical trials, and a focus on rapid accrual is urged. The implementation of biology-directed laboratory investigations, both in association with ongoing clinical trials and as a separate developmental strategy for targeted therapies, is supported as the route to individualized therapy.",
author = "O'Dwyer, {Peter J.} and Eckhardt, {S Gail} and Haller, {Daniel G.} and Joel Tepper and Dennis Ahnen and Stanley Hamilton and Benson, {Al B.} and Mace Rothenberg and Nicholas Petrelli and Lenz, {Heinz Joseph} and Robert Diasio and Raymond DuBois and Daniel Sargent and Jeff Sloan and Johnson, {C. Daniel} and Comis, {Robert L.} and O'Connell, {Michael J.}",
year = "2007",
month = "6",
day = "1",
doi = "10.1200/JCO.2006.08.6900",
language = "English (US)",
volume = "25",
pages = "2313--2321",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "16",

}

TY - JOUR

T1 - Priorities in colorectal cancer research

T2 - Recommendations from the Gastrointestinal Scientific Leadership Council of the Coalition of Cancer Cooperative Groups

AU - O'Dwyer, Peter J.

AU - Eckhardt, S Gail

AU - Haller, Daniel G.

AU - Tepper, Joel

AU - Ahnen, Dennis

AU - Hamilton, Stanley

AU - Benson, Al B.

AU - Rothenberg, Mace

AU - Petrelli, Nicholas

AU - Lenz, Heinz Joseph

AU - Diasio, Robert

AU - DuBois, Raymond

AU - Sargent, Daniel

AU - Sloan, Jeff

AU - Johnson, C. Daniel

AU - Comis, Robert L.

AU - O'Connell, Michael J.

PY - 2007/6/1

Y1 - 2007/6/1

N2 - Emerging technologies have greatly expanded our ability to detect, characterize, and treat colorectal cancer. The Coalition of Cancer Cooperative Groups convened a multidisciplinary panel, the Scientific Leadership Council in GI cancer, to discuss and advise on the priorities and opportunities to advance current and future approaches into the clinical arena to impact most rapidly the morbidity and mortality from this disease. The Council's recommendations for research priorities are the result of engagement of community and academic oncologists, patient advocacy groups, and other stakeholders including the pharmaceutical industry and governmental agencies. We detail some key prospects for investigation in the areas of colon cancer detection, prevention, and surgical and medical management. Many are in early or definitive clinical trials, and a focus on rapid accrual is urged. The implementation of biology-directed laboratory investigations, both in association with ongoing clinical trials and as a separate developmental strategy for targeted therapies, is supported as the route to individualized therapy.

AB - Emerging technologies have greatly expanded our ability to detect, characterize, and treat colorectal cancer. The Coalition of Cancer Cooperative Groups convened a multidisciplinary panel, the Scientific Leadership Council in GI cancer, to discuss and advise on the priorities and opportunities to advance current and future approaches into the clinical arena to impact most rapidly the morbidity and mortality from this disease. The Council's recommendations for research priorities are the result of engagement of community and academic oncologists, patient advocacy groups, and other stakeholders including the pharmaceutical industry and governmental agencies. We detail some key prospects for investigation in the areas of colon cancer detection, prevention, and surgical and medical management. Many are in early or definitive clinical trials, and a focus on rapid accrual is urged. The implementation of biology-directed laboratory investigations, both in association with ongoing clinical trials and as a separate developmental strategy for targeted therapies, is supported as the route to individualized therapy.

UR - http://www.scopus.com/inward/record.url?scp=34250170862&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34250170862&partnerID=8YFLogxK

U2 - 10.1200/JCO.2006.08.6900

DO - 10.1200/JCO.2006.08.6900

M3 - Review article

C2 - 17538178

AN - SCOPUS:34250170862

VL - 25

SP - 2313

EP - 2321

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 16

ER -